APOE and atherosclerosis: To prove the therapeutic role of GI‐Y2 in atherosclerosis, ApoE−/− mice were fed a HFD for 6 weeks, followed by intragastric administration of GI‐Y2 (10 or 20 mg/kg/2 day, i.g.)for an additional 6 weeks (Figure 3A).